A point mutation of the hepatitis B virus is associated with reactivation of the virus in antineoplastic therapy recipients, according to researchers from Taiwan.
A point mutation of the hepatitis B virus is associated with reactivation of the virus in antineoplastic therapy recipients, according to researchers from Taiwan.
台湾的研究者报道，在抗肿瘤治疗的患者中与乙肝病毒一个部位变异相关的病毒复活。